AU743789B2 - Improved process for performing polynucleotide separations - Google Patents
Improved process for performing polynucleotide separations Download PDFInfo
- Publication number
- AU743789B2 AU743789B2 AU75796/98A AU7579698A AU743789B2 AU 743789 B2 AU743789 B2 AU 743789B2 AU 75796/98 A AU75796/98 A AU 75796/98A AU 7579698 A AU7579698 A AU 7579698A AU 743789 B2 AU743789 B2 AU 743789B2
- Authority
- AU
- Australia
- Prior art keywords
- separation media
- eluting solvent
- separation
- column
- polynucleotide fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000926 separation method Methods 0.000 title claims description 187
- 102000040430 polynucleotide Human genes 0.000 title claims description 116
- 108091033319 polynucleotide Proteins 0.000 title claims description 116
- 239000002157 polynucleotide Substances 0.000 title claims description 116
- 238000000034 method Methods 0.000 title claims description 65
- 230000008569 process Effects 0.000 title claims description 26
- 239000002904 solvent Substances 0.000 claims description 110
- 239000012634 fragment Substances 0.000 claims description 96
- 150000001768 cations Chemical class 0.000 claims description 78
- 239000011148 porous material Substances 0.000 claims description 60
- 239000000203 mixture Substances 0.000 claims description 48
- 239000000463 material Substances 0.000 claims description 47
- 229910052751 metal Inorganic materials 0.000 claims description 41
- 239000002184 metal Substances 0.000 claims description 41
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 28
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 23
- 239000010936 titanium Substances 0.000 claims description 23
- 229910052719 titanium Inorganic materials 0.000 claims description 22
- 238000010923 batch production Methods 0.000 claims description 21
- 239000011347 resin Substances 0.000 claims description 21
- 229920005989 resin Polymers 0.000 claims description 21
- 239000002738 chelating agent Substances 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000356 contaminant Substances 0.000 claims description 18
- 229910001220 stainless steel Inorganic materials 0.000 claims description 18
- 239000010935 stainless steel Substances 0.000 claims description 18
- 229920000620 organic polymer Polymers 0.000 claims description 13
- 239000000377 silicon dioxide Substances 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 4
- 239000011260 aqueous acid Substances 0.000 claims description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims 1
- 229910052726 zirconium Inorganic materials 0.000 claims 1
- 238000002347 injection Methods 0.000 description 46
- 239000007924 injection Substances 0.000 description 46
- 239000000243 solution Substances 0.000 description 44
- 108020004414 DNA Proteins 0.000 description 40
- 238000004587 chromatography analysis Methods 0.000 description 33
- 239000002585 base Substances 0.000 description 32
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 24
- 238000011282 treatment Methods 0.000 description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 19
- 239000011651 chromium Substances 0.000 description 18
- 238000013375 chromatographic separation Methods 0.000 description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 16
- 102000053602 DNA Human genes 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000004696 Poly ether ether ketone Substances 0.000 description 14
- 238000011109 contamination Methods 0.000 description 14
- 238000004811 liquid chromatography Methods 0.000 description 14
- 229920002530 polyetherether ketone Polymers 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 238000010828 elution Methods 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 229910021645 metal ion Inorganic materials 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 238000000527 sonication Methods 0.000 description 10
- VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- 229910052742 iron Inorganic materials 0.000 description 9
- 150000002739 metals Chemical class 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- -1 diethylaminoethyl groups Chemical group 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108091027305 Heteroduplex Proteins 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 7
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 6
- 235000011167 hydrochloric acid Nutrition 0.000 description 6
- 229910017604 nitric acid Inorganic materials 0.000 description 6
- 239000003729 cation exchange resin Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 229920001429 chelating resin Polymers 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 4
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical class OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 4
- 235000013980 iron oxide Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102100033786 Paired mesoderm homeobox protein 1 Human genes 0.000 description 3
- 101710112912 Paired mesoderm homeobox protein 1 Proteins 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 229940023913 cation exchange resins Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000002939 deleterious effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical group CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000004190 ion pair chromatography Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052755 nonmetal Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229960003540 oxyquinoline Drugs 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229940005657 pyrophosphoric acid Drugs 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000004697 chelate complex Chemical class 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- GDEBSAWXIHEMNF-UHFFFAOYSA-O cupferron Chemical compound [NH4+].O=NN([O-])C1=CC=CC=C1 GDEBSAWXIHEMNF-UHFFFAOYSA-O 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical group OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical group OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/16—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
- B01D15/166—Fluid composition conditioning, e.g. gradient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/265—Adsorption chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Saccharide Compounds (AREA)
Description
NVO 98/56798 PCT/US98/10228 IMPROVED PROCESS FOR PERFORMING POLYNUCLEOTIDE
SEPARATIONS
FIELD OF THE INVENTION This invention is directed to the separation of polynucleotide fragments by liquid chromatography. More specifically, the invention is directed to a system and method, which enhances the chromatographic separation of polynucleotides on non-polar, wide pore separation media.
BACKGROUND OF THE INVENTION Separation of polynucleotide mixtures is a focus of scientific interest, and numerous researchers have been attempting to achieve technical improvements in various aspects of polynucleotide separation. Anion exchange separation and reverse phase ion pair chromatography are among the most frequently used methods for separating polynucleotide mixtures.
Samples containing mixtures of polynucleotides can result from total synthesis of polynucleotides, cleavage of DNA with restriction endonucleases or RNA, as well as polynucleotide samples which have been multiplied or amplified using polymerase chain reaction (PCR) techniques or other amplifying techniques.
Previous work has focused on developing rapid, high resolution separations, developing separations based on the size of the polynucleotide fragment rather than the base sequence of the fragment, and on developing the ability to collect separated pure fractions of polynucleotides.
WO 98/56798 PCT/US98/10228 W. Bloch (European patent publication No. EP 0 507 591 A2) demonstrated that, to a certain extent, length-relevant separation of polynucleotide fragments was possible on nonporous anion exchanger separation media using eluting solvents containing tetramethylammonium chloride (TMAC). Y. Ohimya et al. (Anal. Biochem., 189:126-130 (1990)) disclosed a method for separating polynucleotide fragments on anion exchange material carrying trimethylammonium groups. Anion exchangers with diethylaminoethyl groups were used by Y. Kato et al. to separate polynucleotide fragments Chromatogr., 478:264 (1989)).
U.S. Patent No. 5,585,236 (1996) to Bonn et al. describes a method for separating polynucleotides using what was characterized as reverse phase ion pair chromatography (RPIPC) utilizing columns filled with non-polar, nonporous polymeric beads. High resolution, rapid separations were achieved using an ion pairing agent (triethylammonium acetate), and acetonitrile/water eluting solvent gradient. This work is important because it is the first example of a size dependent, sequence independent chromatographic separation of double-stranded polynucleotides by Matched Ion Polynucleotide Chromatography (MIPC). Such separations are comparable to those effected by gel electrophoresis, which is currently the technology most widely used for polynucleotide separations. Bonn's work makes it possible to automate separations of polynucleotides based on their size alone. This method differs from traditional reverse phase processes.
Therefore, the term Matched Ion Polynucleotide Chromatography (MIPC) has been applied to the Bonn process to distinguish it from previously known reverse phase processes.
3 The invention of parent application Serial No. 08/748,376 is based on the discovery that trace levels of multivalent metal ions, even when present below the limits of detection, interfere with the MIPC separation process. Special steps to prevent, remove or complex any trace multivalent ions result in enhanced separation of polynucleotides and lower the detection threshold. The inventions of provisional applications Serial No.
60/049,123 filed June 10, 1997; and Serial No. 60/063,835 filed October 30, 1997 under U.S.C. §11l(b) are based on the discovery that nitric acid passivated stainless steel, titanium, and PEEK (polyetherether ketone) surfaces were, contrary to popular belief, sources of multivalent metal ion contamination in the MIPC process. The deleterious effect of multivalent metal cations on polynucleotide separations as observed herein has not been previously reported. We believe that all chromatographic processes which are capable of separating polynucleotides on non-polar, wide pore separation media are impaired by the interference of multivalent metal ions.
Summary of the Invention S 15 According to a first embodiment of the present invention, there is provided a batch process for separating double stranded or single stranded polynucleotide fragments having a selected size from a mixture of polynucleotide fragments including fragments of said selected size comprising: applying a solution of said polynucleotide fragments and a counterion agent to non-polar separation media having a non-polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1-100 microns; contacting the separation media with a first eluting solvent and counterion agent, the first eluting solvent having a concentration of organic component 25 sufficient to release from the separation media all polynucleotide fragments having a size smaller than the selected size and removing the first eluting solvent from the separation media; and contacting the separation media with a second eluting solvent having a concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media; wherein surfaces which are contacted by the solution of polynucleotide AU Sgments and the eluting solvent are material which does not trap or release multivalent Ital cations therefrom.
[l:\DayLib\LIBVV]O8057spec.doc:gcc 3a According to a second embodiment of the present invention, there is provided double stranded or single stranded polynucleotide fragments whenever separated from a mixture of polynucleotide fragments by a process according to the first embodiment of the present invention.
Therefore, the invention provides an improved method for separating a mixture of polynucleotide fragments wherein multivalent cations are eliminated from all the aspects of the separation process. The method comprises applying a solution of said fragments and counterion agent to a column containing separation media having a non-polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1-100 microns. Separation of said fragments is accomplished by eluting said fragments with an eluting solvent gradient of 0 0 *o go• [I:\DayLib\LIBVV]08057specdoc:gcc WO 98/56798 PCT/US98/10228 increasing organic component concentration containing a counterion agent.
Surfaces which are contacted by the solution of the fragments and the eluting solvent are materials which do not release multivalent metal cations therefrom, said materials having been washed to remove traces of organic contaminants therefrom. The method further comprises contacting the solution of said fragments and the eluting solvent with a multivalent cation capture resin to remove any multivalent cations therein before entering the column.
In a preferred embodiment of the invention, the separation media have been treated to remove residual traces of multivalent cations from the surfaces therefrom.
An optimum embodiment of the invention comprises contacting the solution of said fragments and eluting solvent with a multivalent cation capture resin before entering the column, treating the separation media to remove residual traces of multivalent cations from the surfaces therefrom, and ensuring that surfaces which are contacted by the solution of the fragments and the eluting solvent are materials which do not release multivalent metal cations therefrom and cleaning said surfaces to remove any traces of organic contaminants therefrom.
In one embodiment, the polynucleotide fragments are double stranded, having more than 5 base pairs. Such fragments are separated by size or by polarity.
In another embodiment of the invention, the polynucleotide fragments are single stranded having 2 or more nucleotides. Such fragments are separated by size and by polarity.
WO 98/56798 PCT/US98/10228 The separation media are organic polymer, or an inorganic substrate selected from the group consisting of inorganic substrates, silica, zirconia, and alumina. The inorganic substrates support a non-polar material on their surface. Said non-polar material may be organic polymer or long chain, C1 to C24 hydrocarbon groups bound to the inorganic substrate, wherein residual polar groups of the substrate are end capped with trimethylsilyl chloride or hexamethyldisilazane.
In a preferred embodiment, surfaces which are contacted by the solution of polynucleotide fragments and eluting solvent are titanium, coated stainless steel, organic polymer or combinations thereof. Removal of traces of residual multivalent metal cations from the separation process is further ensured by treating said surfaces with a solution comprising aqueous acid and chelating agent, by adding a chelating agent to the solution of polynucleotide mixture and eluting solvent, and by treating the eluting solvent to remove oxygen therefrom.
In one embodiment, the improved method for separating said mixture of polynucleotides comprises Matched Ion Polynucleotide Chromatography.
The improved method of the invention may also be practiced as a batch process for separating polynucleotide fragments having a selected size from a mixture of polynucleotide fragments including fragments of said selected size. The batch process method of the invention comprises applying a solution of said polynucleotide fragments and a counterion agent to nonpolar separation media having a non-polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1-100 microns. The method further comprises contacting the separation WO 98/56798 PCT/US98/10228 media with a first eluting solvent and counterion agent, the first eluting solvent having a concentration of organic component sufficient to release from the separation media all polynucleotide fragments having a size smaller than the selected size and removing the first eluting solvent from the separation media. The selected size fragments are obtained by contacting the separation media with a second eluting solvent having a concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media. Preferably, surfaces which are contacted by the solution of polynucleotide fragments and the eluting solvent are material which does not release multivalent metal cations therefrom.
Following removal of the first eluting solvent, the separation media are rinsed with fresh first eluting solvent to remove residual released polynucleotide fragments therefrom. In a similar manner, following removal of the second eluting solvent the separation media are rinsed with fresh second eluting solvent to remove'residual released polynucleotide fragments of selected size therefrom.
A preferred embodiment of the invention comprises contacting the solution of polynucleotide mixture and eluting solvent with a multivalent cation capture resin before contacting the separation media. In another preferred embodiment the method comprises treating the separation media to remove residual traces of multivalent cations therefrom. Optimally the separation media have been treated to remove residual traces of multivalent cations therefrom and the solution of polynucleotide mixture and eluting solvent have been contacted with a multivalent cation capture resin before contacting the WO 98/56798 PCT/US98/10228 separation media. Said separation media are contained in a column, a web, a membrane, or container.
The batch process can be used to separate mixtures of double stranded polynucleotides or single stranded polynucleotides.
The separation media are organic polymer, or an inorganic substrate selected from the group consisting of inorganic substrates, silica, zirconia, and alumina. The inorganic substrates support a non-polar material on their surface. Said non-polar material may be organic polymer or long chain, C1 to C24 hydrocarbon groups bound to the inorganic substrate, wherein residual polar groups of the substrate are end capped with trimethylsilyl chloride or hexamethyldisilazane.
The surfaces contacted by the solution of polynucleotide fragments and eluting solvent are, preferably, comprised of material selected from the group consisting of titanium, coated stainless steel, and organic polymer, or combinations thereof. Removal of traces of residual multivalent metal cations from the separation process is further ensured by treating said surfaces with a solution comprising aqueous acid and chelating agent, by adding a chelating agent to the solution of polynucleotide mixture and eluting solvent, and by treating the eluting solvent to remove oxygen therefrom.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows a guard disk having a one-piece annular ring.
FIG. 2 is an exploded view of a guard disk having a two-piece annular ring and containing three pads of guard disk material a layer or pad of WO 98/56798 PCT/US98/10228 multivalent cation capture resin which has been incorporated into a fabric or membrane).
FIG. 3 shows an assembled view of the guard disk of FIG. 2.
FIG. 4 shows placement of a chelating guard column and chelating guard disk in a liquid chromatographic system for polynucleotide separation.
FIG. 5 shows placement of a chelating guard disk positioned between a chromatographic separation column and a column top, where the guard disk is in direct contact with a titanium frit at the top portion of the separation column.
FIG 6. shows the chromatography of a 500 base pair DNA fragment on PRX-1 (Sarasep, San Jose, CA) non-polar, wide pore polymer separation media which have been washed (see Example 1) to remove multivalent metal cations thereform.
FIG. 7 shows the effect on the chromatography result shown in FIG. 6 when Cr(lll) cations were added to the column before sample injection.
FIG. 8 shows the effect on the chromatography result of FIG. 7 when a Cr(lll) contaminated column was treated with EDTA prior to sample injection.
FIG 9. shows the chromatography of a 500 base pair DNA fragment on INERTSIL (MetaChem, Torrance, CA) C-18 non-polar, wide pore silica separation media which have been washed with EDTA to remove multivalent metal cations thereform.
FIG. 10 shows the effect on the chromatography result shown in FIG. 9 when Cr(lll) cations were added to the column before sample injection.
WO 98/56798 PCT/US98/10228 FIG. 11 shows the effect on the chromatography result of FIG. when a Cr(lll) contaminated column was treated with EDTA prior to sample injection.
FIG.12 shows the chromatography of a 20 mer single stranded DNA fragment standard (Seq 2A, CTGen, Milpitas, CA) on INERTSIL (MetaChem, Torrance, CA) C-18 non-polar, wide pore silica separation media which have been washed with EDTA to remove multivalent metal cations thereform.
FIG. 13 shows the effect on the chromatography result shown in FIG.
12 when Cr(lll) cations were added to the column before sample injection.
FIG. 14 shows the chromatographic separation at 56 °C of a 209 base pair DNA standard 4 component heteroduplex and homoduplex mixture on a freshly packed, untreated DNASep column (Transgenomic, Inc., San Jose,
CA).
FIG. 15 shows the effect on the chromatography result shown in FIG 14 when the column was treated with EDTA prior sample injection.
DETAILED DESCRIPTION OF THE INVENTION The term polynucleotide, as used herein, is defined as a linear polymer containing an indefinite number of nucleotides, linked from one ribose (or deoxyribose) to another via phosphate residues. The present invention can be used in the separation of RNA or of double or single stranded DNA. For purposes of simplifying the description of the invention and not by way of limitation, the separation of double stranded DNA will be described WO 98/56798 PCT/US98/10228 hereinafter, it being understood that all polynucleotides are intended to be included within the scope of this invention.
The present invention is an improved chromatographic and batch process method for separating mixtures of polynucleotide fragments on wide pore non-polar separation media. The improvement comprises ensuring the removal of all traces of residual multivalent metal cations from the sample mixture, the eluting solvent as well as components of the chromatographic or batch process equipment which contact said sample mixture and eluting solvent. The inventor's observation and demonstration that even traces of multivalent metal cations below the level of detection, degrade polynucleotide separations on wide pore, non-polar separation media and that removal of said cations results in improved separation efficiency and column life is both surprising and novel.
The system used to implement the method of the invention comprises a liquid chromatographic system. The liquid chromatography system comprises a column containing a separation bed of non-polar, wide pore separation media held in the column between porous frits positioned at each end of the column. Other components of the liquid chromatography system include an injection valve and one or more eluting solvent supply means.
Eluting solvent supply means is (are) connected to the injection valve, and the injection valve is connected to the inlet of the chromatographic separation column, by means of conduit tubing), as illustrated in FIG. The chromatography system components mentioned hereinabove and variations thereof are well known in the chromatography art and described in detail in references cited hereinbelow.
WO 98/56798 PCT/US98/10228 In a preferred embodiment of the invention, the mixture of polynucleotide fragments is separated by Matched ion Polynucleotide Chromatography (MIPC). The term "Matched ion Polynucleotide Chromatography" as used herein is defined as a process for separating single and double stranded polynucleotides using non-polar, wide pore separation media, wherein the process uses a counterion agent, and an organic solvent to release the polynucleotides from the separation media.
The pores of the separation media may be contiguous, extend from one surface of the media to another surface of the media. The pores of the separation media may also be non-contiguous, extend into the media at one point on the surface but not through to another point on the surface.
The non-polar, wide pore separation media can be an inorganic substrate, including silica, zirconia, alumina, or other material; or can be polymeric, including crosslinked resins of polystyrene, polyacrylates, polyethylene, or other organic polymeric material. The non-polar, wide pore separation media can also be a "rod column" or "monolith column". Such columns contain silica or polymer separation media which have been formed inside the column as a continuous structure which has through pores or interstitial spaces which allow eluting solvent and analyte to pass through.
The only requirement for the non-polar, wide pore separation media is that they must have a surface that is either intrinsically hydrophobic or be bonded with a material that forms a surface having sufficient hydrophobicity to interact with a counterion agent.
As used herein, the term "non-polar, wide pore separation medium" is defined to denote any material which has surface pores having a diameter WO 98/56798 PCT/US98/10228 that is greater than 30 Angstroms or the approximate size and shape of the smallest polynucleotide fragment in the separation in the solvent medium used therein or greater, and is capable of separating polynucleotide fragments. Although the non-polar, wide pore separation medium may be any shape, those comprising alkylated wide pore polymer beads bead having an average diameter of 1-100 microns are preferred. Such particles are described in the references cited hereinbelow.
Regardless of the source or composition of the non-polar, wide pore reverse phase separation media described above, special precautions are taken to ensure that they are substantially free of multivalent cation contaminants. For example, the separation media are washed with acid followed by methanol to ensure removal of residual multivalent cation contaminants. The separation media can also be washed with EDTA or other chelating agent.
.The concepts, materials, systems and methods related to chromatography on non-polar, wide pore separation media are well known and are described in detail in the following references: Chromatography Today, by Colin F. Poole and Salwa K. Pool, Elsevier (1991); Introduction to Modem Liquid Chromatography, L. R. Snyder and J. J. Kirland, J. Wiley and Sons, Inc. (1979). These references and references contained therein are incorporated in their entirety herein.
Non-polar, wide pore separation media and their use for the separation of polynucleotide mixtures are well known in the art and are commercially available, Hamilton HPLC Application Handbook, (1993), Hamilton Company, Inc., 4970 Energy Way, Reno, Nevada 89502. This, and WO 98/56798 PCT/US98/10228 references contained therein, are incorporated in their entirety herein.
Another reference, which is incorporated in its entirety herein, describing polynucleotide separations on non-polar, wide pore separation media is Chromatography, edition, Part B, edited by E. Heftmann, Elsevier (1992).
Separation of tRNA and DNA fragment mixtures on non-polar, wide pore silica particles is described by R. Bischoff and L.W. McLaughlin, Analytical Biochemistry, 155, 526-533 (1985) and S. Eriksson, et. al., J.
Chromatography, 359, 265-274 (1986).
Monolith or rod columns are commercially avialable form Merck Co (Darmstadt, Germany) and described in the following references: U.S. Patent No. 5453185 to J. M. J. Frechet and F. Svec; M. Petro, et. al., Analytical Chemistry, 68, 315-321 (1996). The references cited above and the references contained therein are incorporated in their entirety herein.
The components of the liquid chromatography system have surfaces "process solution contacting surfaces") which contact process solutions held within the components the eluting solvent supply means) or flowing through the components the porous frits, chromatographic column, injection valve, and conduits). The term "process solution" as used herein refers to any solution (such as the polynucleotide mixture solution and the eluting solvent) which is contained within or flows through any component of the liquid chromatography system during the chromatographic process. The term "process solution contacting surface" refers to any surface of a liquid chromatography system which contacts said process solutions.
The process solution contacting surfaces of the porous frits on either end of the separation column must be made of material which does not WO 98/56798 PCT/US98/10228 release multivalent cations into solutions flowing through the column, or collect said cations from other sources. The material is preferably titanium, coated stainless steel, or organic polymer, or combinations thereof, but is most preferably acid treated titanium as described hereinbelow. The term "coated stainless steel" as used herein refers to stainless steel that has been coated so that it does not release, or is prevented from releasing, multivalent cations. A non-limiting example of a coating material is polytetrafluoroethylene Teflon®). "Coated stainless steel" as used herein also refers to stainless steel that has been pre-treated with an agent such as EDTA or phosphoric acid which forms coordination complexes with multivalent metal ions.
"Passivated stainless steel" as used herein refers to stainless steel that has been treated with an agent that removes oxidized metals and also metals that are easily oxidized such as iron. The most common passivating agent for stainless steel is nitric acid. Nitric acid will removed any oxidized metals, but will also remove iron that is located on the surface of the metal, leaving other metals such as chromium and nickel. Some chelating agents can coat and passivate. EDTA will first coat oxidized metals especially colloidal iron oxide particles. As treatment continues, the EDTA will bind and dissolve the iron oxide. However, as individual iron molecules leave the particle, other chelating molecules must coat the newly exposed surfaces for the surface to remain suitable for polynucleotide separations. A chelating agent does not passivate in the sense that it will only coat metal ions for which it is specific and will not dissolve non-oxidized metals. However, a chelating agent may, eventually, dissolve oxidized metals.
WO 98/56798 PCT/US98/10228 The chelating agents used depend upon the type of ion contamination which is present. For example, Tiron chelating agent is selective for titanium and iron oxides. EDTA is selective for most metal oxides at pH 7. Other chelating agents include cupferron, 8 hydroxyquinoline, oxine, and various iminodiacetic acid derivatives. If the chelating agents are to be used as passivating reagents as well as coating reagents, then it is important that the metal ion chelate complex, for example, EDTA-metal ion complex, is soluble in the fluid. Chelating agents that form insoluble complexes, for example 8hydroxyquinoline, perform coating functions only.
Without wishing to be bound by theory, it is believed that oxidized and positively charged metals, such as oxides of iron on the surface of stainless steel can trap negatively charged molecules such as DNA leading to degradation of the chromatographic separation, and that the pre-treatment masks or shields these surface charges. EDTA can be added, for example, in an amount sufficient to shield any surface sites which would interfere with the chromatographic separation. In one embodiment, a solution of a metal chelating agent such as EDTA can be applied in a batch process to coat the surface, for example by a single injection of EDTA solution into the HPLC system. In another embodiment, EDTA is included as an additive in the eluting solvent in an amount sufficient to complex the metal ions present.
Other components of the liquid chromatography system are preferably titanium, coated stainless steel, or organic polymer such as polyetherether ketone (PEEK) or polyethylene. The preferred system tubing conduit) is titanium, PEEK, or other polymeric material, with an inner diameter of 0.007".
The preferred eluting solvent inlet filters are composed of non-polar, porous, WO 98/56798 PCT/US98/10228 non-stainless steel material, which can be PEEK, polyethylene, or other polymeric material. The preferred solvent pump is also made of a nonstainless steel material; the pump heads, check valves, and solvent filters are preferably titanium, PEEK, or other polymeric material. The preferred means for removing oxygen from the eluting solvent is an inline degasser placed prior to the pump inlet. The sample injection valve is also preferably titanium, PEEK, or other polymeric material. A standard detector and eluting solvent reservoirs can be used, with no modifications necessary.
Materials such as titanium, PEEK and other organic polymers such as polyethylene, have been generally considered to be inert and preferred for the chromatographic separation of biological molecules. We have discovered that these materials, while inert for the prior art processes, can be a source of contaminants which interfere with the chromatographic separation of polynucleotides on non-polar, wide pore separation media. We have also observed that the interference with separation of polynucleotides by these materials becomes more apparent during separations carried out at elevated temperatures, e.g. 56 °C as compared to 50 0C.
In a preferred embodiment of the present invention, all of the process solution-contacting surfaces are subjected to a multivalent cation removal treatment to remove any potential source of multivalent cation contamination.
These surfaces include the column inner surface, porous frits, conduits, eluting solvent supply system, injector valves, mixers, pump heads, and fittings. A non-limiting example of a multivalent cation removal treatment is an acid wash treatment. This wash treatment can include flushing or soaking and can include sonication. An example of an acid wash treatment is WO 98/56798 PCT/US98/10228 sonication of a PEEK or titanium frit in the presence of aqueous nitric acid solution, followed by sonication in water until a neutral pH is achieved. Other treatments include contacting the surfaces with chelating agents such as EDTA, pyrophosphoric acid, or phosphoric acid 30% by weight phosphoric acid).
PEEK and titanium can be treated with dilute acids including nitric and hydrochloric acids. PEEK is not compatible with concentrated sulfuric or concentrated nitric acids. Titanium is not compatible with concentrated hot hydrochloric acid. Treatment with a chelating agent can be performed before, but preferably after treatment with an acid. 20 mM tetrasodium EDTA is a preferred chelating agent treatment.
The preferred treatment for titanium frits is sonication for 10 minutes with cold hydrochloric acid, sonication with water until neutral pH, 2 hour sonication with 0.5 M tetrasodium EDTA, storage several days in 0.5 M tetrasodium EDTA, sonication with water until neutral pH, and then washing with methanol, followed by drying. Preferred treatment for PEEK frits is sonication for 15-30 minutes each with THF, concentrated hydrochloric acid, nitric acid, sonication with water until neutral pH, and then washing with methanol, followed by drying. Although this is a preferred treatment method, the effectiveness of this treatment of PEEK frits can depend on the vendor and lot of material treated. The success of the treatment also depends on the temperature of the polynucleotide separation with higher column temperatures requiring the most complete removal of contamination. If the ionic contaminant is organic, then organic solvents or a combination of organic solvents and acids can be used. Also, organic ionic contaminants WO 98/56798 PCT/US98/10228 can require detergents, soaps or surfactants for removal from the surface.
Nonionic contaminants such as greases and oils will also contaminate the separation column, generally leading to poor peak shape, but depending upon the size of the fragment. Nonionic organic contaminants such as oils will require detergents, soaps or surfactants to remove. Column tubing can be treated under sonication with Decalin (D5039, Sigma) to remove silicon greases and oils. Removal of colloidal metal oxides such as colloidal iron oxide can require repeated or continuous treatment as the surface of the particle is dissolved and new metal oxides are exposed.
The preferred embodiment of the liquid chromatography system of the present invention utilizes methods to minimize the exposure of all process solution contacting surfaces to oxygen. Dissolved oxygen within the eluting solvent, for example, can react with exposed metals on these surfaces to form oxides which will interfere with the chromatographic separation.
The liquid chromatography system preferably employs a degassing method for essentially removing dissolved oxygen from the eluting solvent prior to contact with the rest of the chromatography system. Examples of degassing methods include sparging of the eluting solvent with an inert gas such as argon or helium, or filtering the eluting solvent under vacuum. A preferred method uses a vacuum type degasser which employs inline passage of the eluting solvent over one side of an oxygen permeable membrane system where the other side is subjected to a vacuum. An example of a suitable four channel. vacuum type degasser is DegasetTM, Model 6324 (MetaChem Technologies, Torrance, CA).
WO 98/56798 PCT/US98/10228 In another embodiment of the invention, a stainless steel HPLC system can be used if a component for removing multivalent cations, herein referred to as a "multivalent cation capture resin," is also used. A multivalent cation capture resin is preferably a cation exchange resin or chelating resin. Any suitable cation exchange resin or chelating resin can be used. Preferred cation exchange and chelating resins are described hereinbelow.
Cation exchange resins having an ion exchange moiety selected from the group consisting of iminodiacetate, nitriloacetate, acetylacetone, arsenazo, hydroxypyridinone, and 8-hydroxyquinoline groups are particularly preferred. Cation exchange resins having hydroxypyridinone groups are especially useful for removing iron from the system. Cation exchange resins having iminodiacetate groups are particularly preferred for use in the present invention because of their wide availability in resin format.
A chelating coordination binding) resin is an organic compound which is capable of forming more than one non-covalent bond with a metal.
Chelating resins include iminodiacetate and crown ethers. Crown ethers are cyclic oligomers of ethylene oxide which are able to interact strongly with alkali or alkaline earth cations and certain transition metal cations. A cavity in the center of the molecule is lined with oxygen atoms which hold cations by electrostatic attraction. Each ether has a strong preference for cations whose ionic radius best fits the cavity.
The multivalent cation capture resin is preferably contained in a guard column, guard cartridge, or guard disk. Guard columns and cartridges are frequently used to protect liquid chromatography columns from contamination and are widely available. In their normal use, guard columns and cartridges WO 98/56798 PCT/US98/10228 typically contain packing material which is similar to the stationary phase of the separation column. However, for use in the present invention, the guard column or cartridge must contain a multivalent cation capture resin. The guard disc or guard column must contain particles which trap the metal ions.
For use in the system of the present invention, the guard cartridge or column should be sufficiently large to provide adequate cation capture capacity, but must be small enough to allow effective gradient elution to be used. A preferred guard cartridge has a void volume of less than 5 mL, more preferably, less than 1 mL, so that the eluting solvent gradient is not delayed by more than 5 minutes and, preferably, less than 1 minute. The preferred cartridge has a 10 x 3.2 mm bed volume.
Guard disks are described in detail in U.S. Patent No. 5,338,448, which is incorporated herein by reference in its entirety. For use in the present invention, a guard disk comprises a layer or pad of a multivalent cation capture resin which has been incorporated into a fabric or membrane so that the resin is not separable from the guard disk under liquid flow conditions present during the performance of chromatographic separations.
In its preferred form, the guard disk is circular, having a rigid annular outer ring or collar for easy handling. The annular ring can be constructed of any suitable material which is inert to the chromatographic separation, such as inert conventional engineering plastic. The only requirement for the material is that it must be inert to the eluting solvent and sample and have sufficient dimensional stability. The rigid annular outer ring of the guard disk can comprise a single rigid annular outer ring encircling a disk-shaped pad of guard disk material. As used herein, the term "guard disk material" refers to a WO 98/56798 PCT/US98/10228 layer or pad of multivalent cation capture resin which has been incorporated into a fabric or membrane.
As shown in FIG. 1, one or more pads of guard disk material 2 are placed in the rigid annular ring 4. For example, the fabric can be cut to a circular diameter which securely contacts the inner diameter surface of the annular ring. As the disk holder is tightened against the disk, the top and bottom surfaces of the holder seal against the collar of the guard disk.
Sealing pressure from the guard disk holder is, therefore, applied against the collar of the disk which prevents the material of the guard disk pad from being crushed.
Alternatively, the rigid annular outer ring can comprise two flanged rings, as shown in FIG. 2 and 3, an outer flanged ring 6 and an inner flanged ring 8, where the inner flanged ring is insertable within the flange of the outer ring, forming a press-fit two-piece collar around one or more pads of guard disk material 10. Preferably, the inner diameter of the inner flanged ring will have the same diameter as the separation column bed.
In the two-piece annular ring embodiment shown in FIG. 3, one or more pads of guard disk material 10 having a diameter greater than the inner diameter of the outer flanged ring 6 are positioned within the flanges of the outer ring. The inner flanged ring 8 is then inserted into the outer ring to form a press-fit two-piece annular ring in which the guard disk pad(s) is (are) frictionally held within the press-fit ring or collar. Preferably, the inner diameter of the outer flanged ring and the inner diameter of the inner flanged ring are substantially the same.
WO 98/56798 PCT/US98/10228 Alternatively, the rigid annular outer ring can be incorporated into the guard disk holder or chromatographic column cap. The annular ring is a flange that is part of one or both sides of the disk holder or the column cap.
In this case, the guard disk does not have an outer ring. A circle of the guard disk sheet material is placed into the holder or column cap. The flange in the holder column cap is annular so that, when the holder or column cap is tightened, the flange pinches or seals the outer annular portion of the guard disk. The center portion of the guard disk not pinched is in a chamber or depression in the holder or cap. Fluid flows through the center portion, allowing the guard disk to retain particulate or strongly adsorbed material, but fluid cannot flow around the disk or past the edges. The function of the guard disk is exactly the same as when the collar is part of the guard disk itself.
However, in this case, the collar is part of the holder or column cap.
In a most preferred embodiment of the invention, a multivalent cation capture resin contained in a guard column, guard cartridge, or guard disk is placed upstream of the separation column. Most preferably, the guard column, cartridge, or disk containing the resin is placed upstream of the sample injection valve. Although this is preferably a guard disk, a guard cartridge or column can be used as long as the dead volume of the cartridge or column is not excessive and an effective eluting solvent gradient can be produced.
Optimally, a guard disk, column, or cartridge can be placed before the injection valve and a second guard disk, column, or cartridge also placed between the sample injection valve and the separation column. In certain cases, the second guard disk (or cartridge or column) can be avoided if the 2 WO 98/56798 PCT/US98/10228 contaminants are sufficiently cleaned by a guard column placed upstream of the injection valve, or if the contaminants are avoided through the use of nonmetal or titanium components throughout the HPLC system.
Placement of a chelating guard column and chelating guard disk in a liquid chromatography system for polynucleotide separation is illustrated in FIG. 4. The eluting solvent reservoirs 12 contain eluting solvent inlet filters 14 which are connected to the solvent pump 16 by system tubing 18. The solvent pump 16 is connected to a chelating column 20 by system tubing 18.
The chelating column 20 is connected to the sample injection valve 22 by system tubing 18. The sample injection valve has means for injecting a sample (not shown). The sample injection valve 22 is connected to a chelating guard disk 24 by system tubing 18. The chelating guard disk 24 is connected to the inlet (not shown) of the separation column 26 by system tubing 18. Detector 28 is connected to the separation column 26. As discussed above, the system tubing, eluting solvent inlet filters, solvent pump, sample injection valve, and separation column are preferably made of titanium, coated stainless steel, or organic polymer. The material is preferably treated so that it does not release multivalent cations. The treatment can include treatment with nitric acid, phosphoric acid, pyrophosphoric acid, or chelating agents. In cases, where components of the HPLC do not release metal ion contaminants and are suitable for polynucleotide separations in general and MIPC in particular, then use of the chelating cation exchange guard column or guard disc is not necessary.
In operation, eluting solvent from the eluting solvent reservoirs 12 is pumped through eluting solvent inlet filters 14 by solvent pump 16. By way of 23 WO 98/56798 PCT/US98/10228 system tubing 18, the eluting solvent stream flows through chelating column through sample injection valve 22, through chelating guard disk 24, then into separation column 26. Detector 28 is located downstream from separation column 26.
FIG. 5 illustrates a specific embodiment of the invention in which a chelating guard disk is placed in direct contact with a titanium frit at the top portion of a chromatographic separation column. Column top 30 has conventional fittings for receiving eluting solvent and sample through inlet tubing 32. The column top or cap 30 is fitted and sealably attached to column body 34 containing chromatographic bed 36 using a conventional fitting 38 threaded) or any equivalent fitting capable of tightly sealing the column top to the column body. The column top 30 is adapted to receive the chelating guard disk 40 in a sealing cavity 42. In this embodiment, the guard disk 40 is in direct contact with a titanium column frit 44, which is located at the upstream end of the column body 34 to prevent disturbance of the chromatographic bed 36 when the column top 30 is removed to observe the guard disk.
In operation, solvent pump 46 pumps elution solvent to sample injection valve 48 into column top 30 through chelating guard disk 40 and then through titanium frit 44 before entering chromatographic bed 36. Eluting solvent pressure upstream from the guard disk is measured by pressure transducer 50 which is electrically connected to a display device 52.
As discussed above, a chelating guard column, cartridge, or disk can be used in conjunction with a conventional, stainless steel liquid chromatography system, or with a system containing non-metal or titanium WO 98/56798 PCT/US98/10228 components in order to provide extra protection against ionic contaminants.
For additional column protection, an eluting solvent containing 0.1 mM tetrasodium EDTA or other chelating solution can be used during the performance of polynucleotide separations.
In another aspect of the invention the non-polar, wide pore separation media have been washed to remove any traces of residual multivalent metal cations from the surface thereof. Preferred washing solvents comprise tetrahydrofuran, hydrochloric acid, and water. An example of a preferred washing procedure is described in Examplel.
The methods of the invention comprise using the improved systems described above to separate mixtures of polynucleotide fragments, particularly double-stranded polynucleotide fragments. The methods of the present invention can be used to separate polynucleotide fragments having up to about 1500 base pairs using non-polar, wide pore separation media under the chromatography conditions described herein.
The most preferred method of the invention comprises contacting a solution of a mixture of polynucleotide fragments containing a counterion agent with a multivalent metal cation capture resin, followed by application of said solution to a separation column containing non-polar, wide pore separation media wherein said particles have been washed to remove any traces of residual multivalent cation therefrom. Optimally, the process solution contact surfaces of the system have been passivated, as described hereinabove, to remove multivalent metal cations therefrom. In an optimum configuration, a guard cartridge or guard column containing multivalent cation capture resin is placed at the front of the column or in line between the eluting WO 98/56798 PCT/US98/10228 solvent reservoir and the solvent pump(s) to protect said column and the separation media contained therein from any traces of residual multivalent metal cations in the eluting solvent. The polynucleotide fragments are separated by releasing said fragments from the separation media using an eluting solvent comprising an organic component, water, and a counterion agent. The separation of the polynucleotide components is based on the size or polarity of the fragments. By way of example only, the fragments are released from the separation media in order of size by increasing the concentration of organic component in the eluting solvent. The concentration of the organic component can be increased in stepwise fashion by means of a step gradient, or continuously, by means of a continuous gradient.
The methods used to capture multivalent cations and prevent their presence in the chromatography system, are essential in order to achieve high resolution separations of polynucleotides, especially double stranded DNA, and also to greatly extend the useful life of the separation media.
Evidence demonstrating the detrimental effect of multivalent metal cation contamination on the chromatographic separation of both single stranded polynucleotide fragments and double stranded polynucleotide fragments on non-polar, wide pore silica and polymer separation media is presented in Examples 2 7 and FIGs. 6 Example 2 describes a polynucleotide fragment separation on nonpolar, wide pore organic polymer separation media using the optimized method of the invention compared to a deliberate contamination of the system with multivalent metal cations. While a sharp peak is obtained using the optimized method of the invention, the peak is completely absent when the WO 98/56798 PCT/US98/10228 chromatography system was deliberately contaminated with multivalent metal cations.
Example 3 is identical to Example 2, except that non-polar, wide pore silica separation media were used in the chromatography.
In Example 4, a series of three separations of a 500 base pair DNA fragment was performed using non-polar, wide pore polymer separation media are described. In the first separation, the separation media was washed to remove multivalent cations as described in Example 1 prior to sample injection, and a sharp peak was obtained as shown in FIG. 6.
Deliberate contamination of this separation media with Cr (Ill) cations resulted in a complete loss of the sample peak as shown in FIG. 7. Treatment of the separation particles with EDTA solution to remove the Cr (111) and any other ions which may have been present, partially restored the sample peak as shown in FIG. 8.
Example 5 describes an sequence similar to Example 4, except that non-polar, wide pore silica separation media was used and washed with EDTA solution prior to sample injection. Once again, a sharp sample peak was obtained, as shown in FIG. 9, when the sample was injected onto a column containing cleaned separation media. Deliberate contamination of the separation media with Cr(lll) resulted in complete loss of the sample peak, as shown in FIG. 10. Injection of EDTA solution to remove Cr(lll), or other multivalent cations, followed by injection of the 500 base pair DNA sample, partially restored the sample peak as'shown in FIG. 11.
The deleterious effect of multivalent metal cations on the chromatographic separation of a 20 mer single stranded DNA standard is WO 98/56798 PCT/US98/10228 described in Example 6 and shown by the complete loss of resolution as seen in FIG. 13 (after deliberate Cr (III) contamination) compared to FIG. 12 (column cleaned with EDTA).
The deleterious effect of even trace levels of multivalent cations on demanding chromatographic separation is described in Example 7 and shown in FIGs. 14 and 15. A standard 4 component mixture of double stranded DNA consisting of two 209 base pair homoduplex fragments and two 209 base pair heteroduplex fragments were chromatographed at 56 °C as described in Example 6 on a freshly packed column DNASep column (Transgenomic, Inc., San Jose, CA). FIG. 14 shows only partial resolution of the 4 component mixture. However, when the column was treated with EDTA solution followed by re-injection and elution of the 4 component homoduplex/heteroduplex
DNA
mixture as described in Example 6, a clean separation of all 4 components was achieved, as seen in FIG. 15. This result clearly indicates that trace levels of multivalent cations were present in a freshly packed column, and that said cations interfered with the separation of double stranded DNA fragments.
The method of the invention can also be used to separate polynucleotide mixtures in a batch process useful for production and isolation of pure polynucleotide fragments of a plurality of selected sizes, on a small or large scale. The method of the invention comprises contacting a solution of a mixture of polynucleotide fragments containing a counterion agent with a multivalent metal cation capture resin, followed by applying said solution to non-polar, wide pore separation media. The separation media are held in a container. The container may be a column, a membrane, a container, or a WO 98/56798 PCT/US98/10228 web. The polynucleotide mixture is held on the separation media since the concentration of the organic component of the solvent in which the mixture is dissolved is not sufficient to release the polynucleotide fragments therefrom.
The separation media are then contacted with a first eluting solvent and a counterion agent, said first eluting solvent having a concentration of the organic component sufficient to remove all polynucleotide fragments from the separation media which are smaller than the selected size. The eluting solvent is then separated from the separation media. The separation media are rinsed with the first eluting solvent to remove any remaining released polynucleotides. The separation media are then contacted with a second eluting solvent and counterion agent, said second eluting solvent having a concentration of the organic component sufficient to release the polynucleotide fragment having the selected size from the separation media.
The second eluting solvent is separated from the separation media and the particles are rinsed with the second eluting solvent. This process can be repeated to release polynucleotide of any selected size which are present in the mixture.
Specific eluting solvent compositions required to elute polynucleotide fragments of any specific base pair length can be determined experimentally.
For example, isolation of a 102 base pair fragment from the polynucleotide mixture may be desired, and said fragment may be eluted with 15.9% acetonitrile-water-0.1 M triethylammonium acetate. In this example, the separation media holding the polynucleotide mixture may be contacted with 14.6% acetonitrile-water-0.1 M triethylammonium acetate to remove reaction mixture reagents and additives, as well as all fragments having less than 102 WO 98/56798 PCT/US98/10228 base pairs. Increasing the acetonitrile concentration to 15.9% followed by contact of this eluting solvent with the non-polar, wide pore separation media will release the desired 102 base pair fragment, leaving larger fragments still attached to the separation media. The desired polynucleotide fragment dissolved in the eluting solvent is isolated by separating the eluting solvent from the separation media by filtering, decanting, centrifuging, or any other compatible liquid/solid separation technique. By using a step gradient of increasing acetonitrile concentration, larger particles may be removed in discreet base pair lengths from the separation media and isolated by repeating the procedure described hereinabove.
In a most preferred embodiment of the batch process of the invention, all the methods and procedures used to remove traces of multivalent cations from solvents and surfaces which contact process solution are identical to the methods and procedures described in separation method of the invention described hereinabove. All of process solution contract surfaces are of materials which do not release multivalent cations. Said materials are identical to those described in the separation method of the invention hereinabove.
The methods used to capture multivalent cations and prevent their presence in the batch process described hereinabove, are essential in order to achieve high resolution separations of polynucleotides, especially double stranded DNA, and also to greatly extend the useful life of the separation media.
The concepts, materials, systems and methods related to chromatographic separations on non-polar, wide pore separation media are WO 98/56798 PCT/US98/10228 well known and are described in detail in the following references: Chromatography Today, by Colin F. Poole and Salwa K. Pool, Elsevier (1991); Introduction to Modern Liquid Chromatography, L. R. Snyder and J. J.
Kirland, J. Wiley and Sons, Inc. (1979). These references and references contained therein are incorporated in their entirety herein.
Non-polar, wide pore separation media and their use for the separation of polynucleotide mixtures are well known in the art and are commercially available, Hamilton HPLC Application Handbook, (1993), Hamilton Company, Inc., 4970 Energy Way, Reno, Nevada 89502. This, and references contained therein, are incorporated in their entirety herein.
Another reference, which is incorporated in its entirety herein, describing polynucleotide separations on non-polar, wide pore reverse phase particles is Chromatography, 5 edition, Part B, edited by E. Heftmann, Elsevier (1992).
Separation of tRNA and DNA fragment mixtures on non-polar, wide pore silica particles is described by R. Bischoff and L.W. McLaughlin, Analytical Biochemistry, 155, 526-533 (1985) and S. Eriksson, et. al., J.
Chromatography, 359, 265-274 (1986). Regardless of the source or composition of the non-polar, wide pore separation media, precautions are taken to ensure that they are free of multivalent cation contaminants. For example, the separation media are washed with acid followed by methanol to ensure removal of residual multivalent cation contaminants.
Procedures described in the past tense in the examples below have been carried out in the laboratory. Procedures described in the present tense have not been carried out in the laboratory, and are constructively reduced to practice with the filing of this application.
WO 98/56798 PCT/US98/10228 Example 1 Acid Wash Treatment To Remove Multivalent Metal Cation Contaminants The non-polar, wide pore reverse phase separation media were washed three times with tetrahydrofuran, then two times with methanol. The non-polar, wide pore separation media were then stirred for 12 hours with a mixture containing 100 mL of tetrahydrofuran and 100 mL of concentrated hydrochloric acid. Following this acid treatment, the non-polar, wide pore separation media were washed with tetrahydrofuran/water until neutral (pH The non-polar, wide pore separation media were then dried at 40 0
C
for 12 hours.
Example 2 Standard Procedure for Demonstrating the Effects of Colloidal Iron on Non-polar, Wide pore Polymer Separation Media Non-polar, wide pore PRX-1 separation media (Sarasep, Inc. San Jose, CA.) of polystyrene/divinylbenzene polymer having a pore size of 50 200 Angstroms (average pore size is 80 Angstroms) and a bead diameter of microns are washed as described in Example 1 and packed in a 4.6 x 50 mm HPLC column. A sample (5 IL, 20 ng) of 80 base pair DNA standard solution from purified pUC18 DNA Hae III restriction enzyme digest (Sigma-Aldrich, D6293) is injected onto the column. The chromatography is conducted under the following conditions: Eluting solvent A: 0.1 M Triethylammonium acetate (TEAA), pH 7.2; Eluting solvent B: 0.1 M TEAA, 25% acetonitrile; Gradient: Time (min) %A %B 0.0 65 3.0 45 32.
WO 98/56798 PCT/US98/10228 10.0 35 14.0 0 100 16.0 65 The flow rate is 0.75 mL/min, UV detection at 260 nm, column temp.
510C. A peak for the 80 base pair DNA fragment is obtained. Some columns, depending on the packing volume and packing polarity, may require longer time for elution of some changes in the driving solvent concentration.
A 0.05M aqueous solution of Fe(CI) 3 is prepared and allowed to stand at ambient temperature for four hours. A 100 gL sample of the resulting colloidal iron suspension is injected onto the column and allowed to stand for five minutes. Subsequent injection of 5 gL of the above described 80 base pair DNA standard solution followed by the identical gradient elution conditions described above, shows a complete absence of any peak.
Example 3 Standard Procedure for Demonstrating the Effects of Colloidal Iron on Non-polar, Wide pore Silica Separation Media INERTSIL (MetaChem, Torrance, CA), a 5um C-18 non-polar, wide pore separation medium having 200 Angstrom pores was packed in a 4.6 x mm HPLC column and cleaned with 5 injections of 0.1M NaEDTA. A base pair DNA standard (5 IL) is injected and eluted as described in Example 2. A peak for the 80 base pair DNA standard is obtained.
An injection of the colloidal iron suspension is made as described in Example 3. Subsequent injection of the 80 base pair DNA standard and elution as described in Example 3 shows a complete absence of any peak.
Example 4 WO 98/56798 PCT/US98/10228 Standard Procedure for Demonstrating the Effects of Chromium(lll) On The Separation of Double Stranded DNA Using Non-polar, Wide Pore Polymer Separation Media Non-polar, wide pore PRX-1 separation media (Sarasep, Inc., San Jose, CA) of polystyrene/divinylbenzene polymer having a 5 micron diameter and a pore size of 50 200Angstroms (80 Angstrom average pore size) was washed as described in Example 1 and packed in 4.6 x 50 mm HPLC column.
A sample (5gL, 20 ng) of 500 base pair DNA standard solution from GeneAmpR Lambda Control Reagent, N808-0008, (Perkin Elmer, Foster City, CA) was injected onto the column. The chromatography was conducted under the following conditions: eluting solvent A; 0.1M triethylammonium acetate (TEAA), pH 7.2; eluting solvent B; 0.1 M TEAA, 25% acetonitrile gradient: Time (min) %A %B 0.0 60 14 0 100 17 60 The flow rate was 0.60 mL/min, UV detection at 260 nm, column temperature 50 A peak for the 500 base pair DNA fragmetn was obtained, as shown in Fig. 6.
A 520 ppm aqueous solution of Cr(lll) was prepared from Cr 3 (S04)2.
12H 2 0 and injected onto the column. The 17 min. solvent gradient was flowed through the column. Injection of 5 pL of the 500 base pair DNA standard onto the column and elution as described above, showed a complete absence of any peak (FIG. 7).
WO 98/56798 PCT/US98/10228 A subsequent column cleanup with 3 injections, 10 pL each, of 0.1M Na 4 EDTA was followed by equilibration to a constant baseline.
A re-injection of 5 gL of the 500 base pair DNA standard showed a reappearance of the a peak (FIG.8) having an area of about 50% of the original injection (FIG. 6).
Example Standard Procedure for Demonstrating the Effects of Chromium(lll) On The Separation of Double Stranded DNA Using Non-polar, Wide Pore Silica Separation Media INERTSIL (MetaChem, Torrance, CA) 5 micron C-18 non-polar, wide pore (150 Angstrom pores) separation media was packed into a 4.6 x 50 mm HPLC column and cleaned with 5 injections of 0.1 M Na 4 EDTA. A 500 base pair DNA standard was injected onto the column and eluted as described in Example. 4. A peak fo rthe 500 bas pair standard is shown in FIG. 9.
Injection of the Cr(lll) solution as described in Example 4 followed by elution as described in Example 4, showed a complete absence of a peak as shown in FIG. Three 10 mL injections of NaEDTA as described in Example 4 follwed by reinjection of the 500 base pair DNA standard and elution as described in Example 4, showed a peak (FIG. 11)corresponding to the 500 base pair DNA standard Example 6 The Effect of Chromium(lll) on The Separation of Single Stranded DNA Using Non-polar, Wide Pore Silica Separation Media WO 98/56798 PCT/US98/10228 The column described in Example 5 was cleaned with Na 4 EDTA as decribed in Example 5 and equilibrated with 60%A eluting solvent to a constant bse line. A 20 mer, single stranded DNA standard (Seq2A purchased from CTGen, Milpitas, CA) was injected onto the column and eluted with the gradient protocol of Example 4. FIG 12 shows a major peak corresponding to the 20 mer standard and some well resolved impurity peaks.
A single 5 mL injection of the Cr(lll) solution described in Example 4 was followed by re-injection of the 20 mer standard and elution using the gradient protocol of Example 4. The results seen in FIG. 13 show a greatly diminished peak corresponding to the 20 mer, and essentially no resolution of the impurities.
This example clearly show that metal contamination has a negative effect on the chromatography of single stranded DNA but not to the same extent as it has on double stranded DNA.
An additional injection of 5 gL onto the column followed by another injection of the 20 mer standard as described above, did result in complete elimination of the 20 mer peak. However, after 10 injections of 0.1M Na 4 EDTA to remove metal contamination, as described above, followed by another injection of the 20 mer standard, did restore the peak corresponding to the 20 mer standard. However, the peak shape was distorted and broad.
Example 7 The Effect Of Metal Contamination On The Separation Of Heteroduplexes And Homoduplexes A freshly packed DNASep column (Transgenomic, Inc., San Jose, CA) was equilibrated with eluting solvent 50%A. A mixture of DNA 209 base pair WO 98/56798 PCT/US98/10228 standard fragments (Transgenomic, Inc., San Jose, CA, Cat. No. 560012) consisting of 2 heteroduplex DNA fragmetns and 2 homoduplex DNA fragments was injected (5 gL) onto the column. The mixture was eluted at a flow rate of 0.9 mL/min using the following gradient program: Time (min) %A %B 0.0 50 47 53 40 0 100 6.5 50 50 When the chromatography was run at 50 °C a normal size based separation was observed, a single peak of unresolved hetroduplex and homoduplex 209 base pair fragments was observed.
FIG. 14 shows the results of a chromatography run at 56 on a newly packed column. Three peaks are seen. The low retention time pair corresponds to the two heteroduplexes. The large higher retention time peak corresponds to the unresolved homoduplex peaks. The lack of complete separation of all four fragments indicated that the column, though freshly packed, contained multivalent metal cation contaminants.
Column cleanup with 5, 10 gL injections of 0.1M NaEDTA was followed by washing with 25% actonitrile, 5% acetic acid, and equilibration to constant base line with eluting solvent 50%A. Injection of the 209 fragment standard homoduplex/heteroduplex mixture and elution with the gradient protocol described above, gave complete separation of the mixture into four WO 98/56798 PCT/US98/10228 peaks, two homoduplex and 2 heteroduplex peaks as depicted in FIG.
The results described in this example indicate that multivalent metal cation contamination is more critical at higher column temperatures, especially as related to the difficult separation of homoduplex and heteroduplex fragments of identical base pair length.
Claims (12)
1. A batch process for separating double stranded or single stranded polynucleotide fragments having a selected size from a mixture of polynucleotide fragments including fragments of said selected size comprising: applying a solution of said polynucleotide fragments and a counterion agent to non-polar separation media having a non-polar surface, wherein said separation media have a pore size greater than 30 Angstroms and an average diameter of 1-100 microns; contacting the separation media with a first eluting solvent and counterion agent, the first eluting solvent having a concentration of organic component sufficient to release from the separation media all polynucleotide fragments having a size smaller than the selected size and removing the first eluting solvent from the separation media; and contacting the separation media with a second eluting solvent having a i5 concentration of organic component sufficient to release from the separation media the polynucleotide fragments having the selected size and removing the second eluting solvent from the separation media; wherein surfaces which are contacted by the solution of polynucleotide fragments and the eluting solvent are material which does not trap or release multivalent metal cations therefrom.
2. A batch process of claim 1 wherein the separation media are rinsed with fresh first eluting solvent following step to remove residual released polynucleotide fragments therefrom, and the separation media are rinsed with fresh second eluting solvent following step to remove residual released polynucleotide fragments of 25 selected size therefrom.
3. A batch process of claim 1 or claim 2 wherein the solution of polynucleotide mixture and eluting solvent have been contacted with a multivalent cation capture resin before contacting the separation media.
4. A batch process of any one of claims 1 to 3 wherein the separation media are contained in a column, a web, a membrane, or container.
A batch process of any one of claims 1 to 4 wherein said separation media are organic polymer or inorganic substrates selected from the group consisting of inorganic substrates, silica, zirconium, and alumina. [1:\DayLib\LLBVV]08057spec.doc:gcc
6. A batch process of any one of claims 1 to 5 wherein the surfaces contacted by the solution of polynucleotide fragments and eluting solvent are comprised of material selected from the group consisting of titanium, coated stainless steel, and organic polymer, or combinations thereof.
7. A batch process of claim 6 wherein traces of residual multivalent metal cations have been removed from said surfaces by treating said surfaces with a solution comprising aqueous acid and chelating agent.
8. A batch process of claim 6 wherein organic contaminants have been removed from said surfaces.
9. A batch process of any one of claims 1 to 8 wherein said solution of polynucleotide mixture and eluting solvent contain a chelating agent whereby any trace of multivalent metal cations in the solution are captured.
A batch process of any one of claims 1 to 9 wherein the eluting solvent has been treated to remove oxygen therefrom. 15
11. A batch process for separating double stranded or single stranded polynucleotide fragments having a selected size from a mixture of polynucleotide fragments of said selected size, said process being substantially as hereinbefore described S: with reference to any one of the examples.
12. Double stranded or single stranded polynucleotide fragments whenever separated from a mixture of polynucleotide fragments by a process according to any one S t of claims 1 to 11. Dated 22 November, 2001 Transgenomic, Inc. Patent Attorneys for the Applicant/Nominated Person 25 SPRUSON FERGUSON [1:\DayLib\LIBvV]08057spec.doc:gcc
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4912397P | 1997-06-10 | 1997-06-10 | |
| US60/049123 | 1997-06-10 | ||
| US6383597P | 1997-10-30 | 1997-10-30 | |
| US60/063835 | 1997-10-30 | ||
| PCT/US1998/010228 WO1998056798A1 (en) | 1997-06-10 | 1998-05-19 | Improved process for performing polynucleotide separations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU7579698A AU7579698A (en) | 1998-12-30 |
| AU743789B2 true AU743789B2 (en) | 2002-02-07 |
Family
ID=26726874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU75796/98A Ceased AU743789B2 (en) | 1997-06-10 | 1998-05-19 | Improved process for performing polynucleotide separations |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1025113A4 (en) |
| JP (1) | JP2001524133A (en) |
| AU (1) | AU743789B2 (en) |
| CA (1) | CA2288813A1 (en) |
| WO (1) | WO1998056798A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6475388B1 (en) | 1996-11-13 | 2002-11-05 | Transgenomic, Inc. | Method and system for RNA analysis by matched ion polynucleotide chromatography |
| US7138518B1 (en) | 1996-11-13 | 2006-11-21 | Transgenomic, Inc. | Liquid chromatographic separation of polynucleotides |
| US6576133B2 (en) | 1996-11-13 | 2003-06-10 | Transgenomic, Inc | Method and system for RNA analysis by matched ion polynucleotide chromatography |
| US6258264B1 (en) | 1998-04-10 | 2001-07-10 | Transgenomic, Inc. | Non-polar media for polynucleotide separations |
| AU2001227653A1 (en) * | 2000-03-09 | 2001-09-17 | Transgenomic, Inc. | Method and system for rna analysis by matched ion polynucleotide chromatography |
| AU2001259113A1 (en) * | 2000-04-21 | 2001-11-07 | Transgenomic, Inc. | Apparatus and method for separating and purifying polynucleotides |
| US6521411B2 (en) * | 2000-09-28 | 2003-02-18 | Transgenomic, Inc. | Method and system for the preparation of cDNA |
| AU2001287078A1 (en) * | 2000-11-16 | 2002-05-27 | Transgenomic, Inc. | Liquid chromatographic separation of polynucleotides |
| US20020086291A1 (en) * | 2000-11-29 | 2002-07-04 | Hornby David P. | Methods and reagents for analysis of rna structure and function |
| WO2003031580A2 (en) | 2001-10-05 | 2003-04-17 | Transgenomic, Inc. | Methods and compositions for mutation analysis by liquid chromatography |
| AU2002346522A1 (en) * | 2002-11-25 | 2004-06-18 | Varian, Inc. | Irregularly-shaped macroporous copolymer particles and methods of using same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338448A (en) * | 1992-10-16 | 1994-08-16 | Sarasep, Inc. | Method of preventing contamination of a chromatography column |
| AT398973B (en) * | 1992-11-18 | 1995-02-27 | Bonn Guenther Dr | METHOD FOR SEPARATING NUCLEIC ACIDS |
| US5482628A (en) * | 1994-04-15 | 1996-01-09 | Upchurch Scientific, Inc. | Column for liquid chromatography |
-
1998
- 1998-05-19 JP JP50248799A patent/JP2001524133A/en active Pending
- 1998-05-19 WO PCT/US1998/010228 patent/WO1998056798A1/en not_active Ceased
- 1998-05-19 EP EP98923524A patent/EP1025113A4/en not_active Withdrawn
- 1998-05-19 AU AU75796/98A patent/AU743789B2/en not_active Ceased
- 1998-05-19 CA CA002288813A patent/CA2288813A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001524133A (en) | 2001-11-27 |
| AU7579698A (en) | 1998-12-30 |
| EP1025113A4 (en) | 2002-01-09 |
| CA2288813A1 (en) | 1998-12-17 |
| EP1025113A1 (en) | 2000-08-09 |
| WO1998056798A1 (en) | 1998-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5972222A (en) | Process for performing polynucleotide separations | |
| US6251272B1 (en) | System and column for performing polynucleotide separations using liquid chromatography | |
| US5772889A (en) | System and method for performing nucleic acid separations using liquid chromatography | |
| US6471866B1 (en) | Process for performing polynucleotide separations | |
| US6030527A (en) | Apparatus for performing polynucleotide separations using liquid chromatography | |
| EP1023306B1 (en) | System and method for performing polynucleotide separations using liquid chromatography | |
| US6017457A (en) | Method for performing polynucleotide separations using liquid chromatography | |
| US6066258A (en) | Polynucleotide separations on polymeric separation media | |
| AU743789B2 (en) | Improved process for performing polynucleotide separations | |
| McCormick | A solid-phase extraction procedure for DNA purification | |
| US6174441B1 (en) | Method for performing polynucleotide separations using liquid chromatography | |
| Hawk et al. | Chromatography of biological materials on polyethylene glycol treated controlled-pore glass | |
| US20020062017A1 (en) | Method and system for the preparation of cDNA | |
| WO2000069872A2 (en) | pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS | |
| US6579459B2 (en) | System and method for performing polynucleotide separations using liquid chromatography | |
| US5986085A (en) | Matched ion polynucleotide chromatography (MIPC) process for separation of polynucleotide fragments | |
| US20010042714A1 (en) | Method and system for RNA analysis by matched ion polynucleotide chromatography | |
| US6177559B1 (en) | Process for separation of polynucleotide fragments | |
| JP2002511147A (en) | One-step apparatus and method for biomolecule concentration and purification | |
| AU777251B2 (en) | Polynucleotide separations on polymeric separation media | |
| US6482317B2 (en) | Polynucleotide separations on polymeric separation media | |
| Wulfson et al. | HPLC of nucleotides. II. General methods and their development for analysis and preparative separation. An approach to selectivity control | |
| WO2001066216A1 (en) | Method and system for rna analysis by matched ion polynucleotide chromatography | |
| Chang et al. | Purification of G6PDH from unclarified yeast cell homogenate using expanded bed adsorption (EBA) with STREAMLINETM red H-E7B | |
| JPS63281051A (en) | Treatment of sample |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |